Home Chronic Diseases Tags

View the Latest: Chronic Diseases

Filter

List Grid

31 - 40 of 56 Results

  • Data Note: Medicaid’s Role in Providing Access to Preventive Care for Adults

    Issue Brief

    Chronic illness is prevalent in the adult Medicaid population. Preventive care, including immunizations and regular screenings that permit early detection and treatment of chronic conditions, improves the prospects for better health outcomes. This Data Note focuses on Medicaid’s role in providing access to preventive care for low-income adults.

  • The Diseases We Spend Our Health Dollars On

    From Drew Altman

    In this column for The Wall Street Journal's Think Tank, Drew Altman explains how a recent Bureau of Economic Analysis report makes the nation’s health care spending more tangible by breaking it down by disease.

  • Views and Experiences of Puerto Ricans One Year After Hurricane Maria

    Report

    This partnership survey from The Washington Post and the Kaiser Family Foundation explores how Puerto Ricans are faring one year after Hurricane Maria struck the U.S. territory. This face-to-face survey of those living in Puerto Rico examines the impact the hurricane had on their lives, including their housing situation, financial status, and mental and physical health. It also covers issues of access to water and electricity and Puerto Ricans' views of the government’s response to the storm and its recovery. This is the first, and only, comprehensive, island-wide representative survey to assess a broad array of impacts from Hurricane Maria and hear directly from the people of Puerto Rico about what they experienced and what the ongoing needs are.

  • FDA’s Approval of Biogen’s New Alzheimer’s Drug Has Huge Cost Implications for Medicare and Beneficiaries

    Issue Brief

    The question of what would happen when a new, expensive prescription drug comes to market for a disease like Alzheimer’s that afflicts millions of people has loomed large in discussions over drug prices in the U.S. This brief analyzes the cost implications for Medicare and beneficiaries associated with Biogen's new FDA-approved Alzheimer's drug, which will cost $56,000 per year.

  • Utilization of Health Care Services by Medicaid Expansion Status

    Issue Brief

    Some critics of Medicaid expansion have argued that expansion diverts resources away from other groups of Medicaid enrollees, including people with disabilities and children, and that expansion enrollees are “able-bodied” implying they have minimal health care needs. However, data show that expansion states spend more per enrollee overall and on each eligibility group than non-expansion states and that nearly half of expansion enrollees have a chronic condition. This data note analyzes 2021 Medicaid claims data to compare utilization of health care services among Medicaid expansion enrollees with other Medicaid enrollees in expansion states and to compare utilization of health care services among adult Medicaid enrollees living in expansion and non-expansion states.

  • The Public’s Health Care Agenda for the 113th Congress

    Poll Finding

    As the 113th Congress is sworn in, and President Barack Obama begins his second term of office, a comprehensive new Kaiser Family Foundation/Robert Wood Johnson Foundation/Harvard School of Public Health survey queried the public about their priorities for, and views on, a wide range of health and health policy issues.